» Articles » PMID: 14432941

Device for Inhalation Exposure of Animals to Spores

Overview
Date 1960 Apr 1
PMID 14432941
Citations 19
Authors
Affiliations
Soon will be listed here.
Citing Articles

An inhalation model of airway allergic response to inhalation of environmental Aspergillus fumigatus conidia in sensitized BALB/c mice.

Hoselton S, Samarasinghe A, Seydel J, Schuh J Med Mycol. 2010; 48(8):1056-65.

PMID: 20482452 PMC: 3113699. DOI: 10.3109/13693786.2010.485582.


In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis.

Hoeben B, Burgess D, McConville J, Najvar L, Talbert R, Peters J Antimicrob Agents Chemother. 2006; 50(4):1552-4.

PMID: 16569882 PMC: 1426984. DOI: 10.1128/AAC.50.4.1552-1554.2006.


The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy.

Stephens-Romero S, Mednick A, Feldmesser M Infect Immun. 2004; 73(1):114-25.

PMID: 15618146 PMC: 538996. DOI: 10.1128/IAI.73.1.114-125.2005.


Effect of granulocyte colony-stimulating factor combination therapy on efficacy of posaconazole (SCH56592) in an inhalation model of murine pulmonary aspergillosis.

Patera A, Menzel F, Jackson C, Brieland J, Halpern J, Hare R Antimicrob Agents Chemother. 2004; 48(8):3154-8.

PMID: 15273138 PMC: 478512. DOI: 10.1128/AAC.48.8.3154-3158.2004.


Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: comparative studies in two laboratories.

Najvar L, Cacciapuoti A, Hernandez S, Halpern J, Bocanegra R, Gurnani M Antimicrob Agents Chemother. 2004; 48(3):758-64.

PMID: 14982761 PMC: 353105. DOI: 10.1128/AAC.48.3.758-764.2004.